Search - tctmd.com

Displaying 201 - 220 of 867

Sort: Relevancy | Date

‘Astonishing’ Rates of CVD Linked to Lead Exposure

News Daily News

‘Astonishing’ Rates of CVD Linked to Lead Exposure

September 13, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Subclinical HFpEF Common in Patients Undergoing AF Ablation

News Daily News

Subclinical HFpEF Common in Patients Undergoing AF Ablation

September 08, 2023

Worldwide, Care for Women With Acute HF Falls Short

News Daily News

Worldwide, Care for Women With Acute HF Falls Short

September 08, 2023

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

News Daily News

Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF

September 07, 2023

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

News Daily News

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

Yael L. Maxwell

September 06, 2023

TCTMD’s Top 10 Most Popular Stories for August 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

September 04, 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

September 01, 2023

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

News Conference News ESC 2023

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

September 01, 2023

September 2023 News Roundup

News Opinion CV Team Dispatch

September 2023 News Roundup

September 01, 2023

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

August 31, 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

News Conference News ESC 2023

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

Yael L. Maxwell

August 31, 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

August 30, 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

News Daily News ESC 2023

Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN

Michael O'Riordan

August 30, 2023

Cardiac Resynchronisation Therapy Upgrade in Heart Failure with Right Ventricular Pacing A Multicentre Randomised Controlled Trial

Presentation ESC 2023

Cardiac Resynchronisation Therapy Upgrade in Heart Failure with Right Ventricular Pacing A Multicentre Randomised Controlled Trial

Presenter: Béla Merkely

August 28, 2023

The HEART-FID Trial: Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency

Presentation ESC 2023

The HEART-FID Trial: Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency

Presenter: Robert Mentz

August 28, 2023

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

News Conference News ESC 2023

MULTISTARS AMI: Immediate Complete PCI in STEMI as Safe as Staged Revascularization

Michael O'Riordan

August 28, 2023

CASTLE-HTx: AF Ablation Boosts Outcomes in Advanced Heart Failure

News Conference News ESC 2023

CASTLE-HTx: AF Ablation Boosts Outcomes in Advanced Heart Failure

August 28, 2023

DICTATE AHF: Efficacy and Safety of Dapagliflozin in Acute Heart Failure

Presentation ESC 2023

DICTATE AHF: Efficacy and Safety of Dapagliflozin in Acute Heart Failure

Presenter: Zachary Cox

August 28, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.